Nature's Sunshine Products, Inc. (NASDAQ:NATR – Get Rating) major shareholder Wynnefield Partners Small Cap bought 1,569 shares of the firm's stock in a transaction that occurred on Thursday, September 15th. The shares were purchased at an average cost of $8.93 per share, for a total transaction of $14,011.17. Following the completion of the transaction, the insider now owns 774,547 shares of the company's stock, valued at $6,916,704.71. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Major shareholders that own at least 10% of a company's stock are required to disclose their sales and purchases with the SEC.
Wynnefield Partners Small Cap also recently made the following trade(s):
Get Nature's Sunshine Products alerts:- On Thursday, September 8th, Wynnefield Partners Small Cap bought 1,332 shares of Nature's Sunshine Products stock. The shares were purchased at an average cost of $9.30 per share, for a total transaction of $12,387.60.
- On Monday, August 29th, Wynnefield Partners Small Cap bought 1,428 shares of Nature's Sunshine Products stock. The shares were purchased at an average cost of $9.80 per share, for a total transaction of $13,994.40.
- On Thursday, August 25th, Wynnefield Partners Small Cap bought 9,622 shares of Nature's Sunshine Products stock. The shares were purchased at an average cost of $9.66 per share, for a total transaction of $92,948.52.
- On Tuesday, August 23rd, Wynnefield Partners Small Cap bought 1,154 shares of Nature's Sunshine Products stock. The shares were purchased at an average cost of $10.00 per share, for a total transaction of $11,540.00.
Nature's Sunshine Products Trading Up 0.5 %
NASDAQ:NATR opened at $8.66 on Thursday. Nature's Sunshine Products, Inc. has a 1 year low of $8.46 and a 1 year high of $19.26. The firm has a 50 day moving average of $10.02 and a 200-day moving average of $12.78. The stock has a market capitalization of $166.49 million, a P/E ratio of 10.96 and a beta of 0.79.
Institutional Inflows and Outflows
Institutional investors have recently bought and sold shares of the stock. Prescott Group Capital Management L.L.C. raised its position in shares of Nature's Sunshine Products by 23.3% during the 2nd quarter. Prescott Group Capital Management L.L.C. now owns 1,245,466 shares of the company's stock valued at $13,289,000 after acquiring an additional 235,375 shares during the last quarter. Paradigm Capital Management Inc. NY grew its holdings in shares of Nature's Sunshine Products by 4.9% in the 2nd quarter. Paradigm Capital Management Inc. NY now owns 1,131,330 shares of the company's stock valued at $12,071,000 after buying an additional 52,500 shares during the period. Renaissance Technologies LLC grew its holdings in shares of Nature's Sunshine Products by 2.3% in the 2nd quarter. Renaissance Technologies LLC now owns 723,530 shares of the company's stock valued at $7,720,000 after buying an additional 16,333 shares during the period. Dimensional Fund Advisors LP grew its holdings in shares of Nature's Sunshine Products by 5.9% in the 1st quarter. Dimensional Fund Advisors LP now owns 560,594 shares of the company's stock valued at $9,429,000 after buying an additional 31,027 shares during the period. Finally, Acadian Asset Management LLC grew its holdings in shares of Nature's Sunshine Products by 49.9% in the 1st quarter. Acadian Asset Management LLC now owns 338,095 shares of the company's stock valued at $5,683,000 after buying an additional 112,502 shares during the period. Institutional investors own 75.24% of the company's stock.Wall Street Analysts Forecast Growth
Separately, TheStreet downgraded Nature's Sunshine Products from a "b-" rating to a "c+" rating in a research report on Friday, July 8th.
About Nature's Sunshine Products
(Get Rating)
Nature's Sunshine Products, Inc, a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Read More
- Get a free copy of the StockNews.com research report on Nature's Sunshine Products (NATR)
- The Worst May be Over for Target, But is the Stock Safe to Buy?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Two Fun Stocks The Insiders Are Buying
- Novavax Remains a Risk-On Stock in a Risk-Off Market
- 3 Defensive Stocks With 60-Year Dividend Hike Streaks
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.